Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbbVie Inc (ABBV) vs Plby Group Inc (PLBY) Price & Performance

AbbVie IncTrade
Plby Group IncTrade

Price performance (Past 24H)

Key statistics

AbbVie Inc vs Plby Group Inc — how do they compare? AbbVie Inc trades at $248.48 (market cap $441.94B), while Plby Group Inc trades at $1.35 (market cap $162.94M). The key difference: AbbVie Inc is far larger — about 2712.3× Plby Group Inc's market cap, and AbbVie Inc pays a 2.77% dividend while Plby Group Inc pays none. Which is the better fit depends on your goals.

ABBVPLBY
Market Cap
$441.94B$162.94M
Sector
HealthConsumer Cyclical
52-Week High
$263.58$2.71
52-Week Low
$197.38$1.11
Enterprise Value
$506.19B$308.52M
Dividend Yield
2.77%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AbbVie Inc

AbbVie (ABBV) trades at $247.91, up 0.76% today, with a bullish technical signal and strong analyst support. Recent earnings beats and a 70.73% buy consensus highlight robust fundamentals, driven by Skyrizi and Rinvoq growth offsetting Humira declines. Positive news includes Phase 2 ovarian cancer data and institutional stake increases, reinforcing momentum.

Outlook remains positive with a $278.69 price target, though risks include patent cliffs and debt levels. Revenue growth and dividend stability offer appeal, but investors should monitor competitive pressures and regulatory developments for sustained performance.

Plby Group Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AbbVie Inc

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

Read more on ABBV

About Plby Group Inc

PLBY Group Inc is a pleasure and leisure company. The company's segment includes Licensing, Direct-to-Consumer, and Digital Subscriptions and Content. It generates maximum revenue from the Direct-to-Consumer segment. Direct-to-Consumer operations include consumer products sold through third-party retailers or online direct-to-customer. Geographically, it derives a majority of revenue from the United States.

Read more on PLBY